Swiss Re’s Colgate-Palmolive CL Stock Holding History

Swiss Re’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Buy	1,106 +931	+532%	+$81.5K	0.01%	229
2026 Q1	$14.9K	Hold	175	–	–	0.09%	173
2025 Q4	$13.8K	Buy	+175	New	+$13.7K	﹤0.01%	182

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Swiss Re's CL Position: Q2 2026 in Review

Swiss Re increased its Colgate-Palmolive (CL) stake by 532% in Q2 2026, buying an estimated $81.5K and bringing the position to 1,106 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #229.

Swiss Re first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Swiss Re held 1,106 shares of Colgate-Palmolive worth $101K as of Q2 2026.
Swiss Re bought 931 Colgate-Palmolive shares in Q2 2026, an estimated $81.5K.
Colgate-Palmolive made up 0.01% of Swiss Re's portfolio in Q2 2026, its #229 holding.
Swiss Re first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Swiss Re's 13F filing for Q2 2026, filed 11 Aug 2026.